文献速递急性肾损伤肾小球疾病肾移植

COVID-19患者急性肾损伤或蛋白尿的肾活检多中心临床病理关联研究

Multicenter Clinicopathologic Correlation of Kidney Biopsies Performed in COVID-19 Patients Presenting With Acute Kidney Injury or Proteinuria.
PubMed 文献 · Am J Kidney Dis · 2020-10-10

该多中心病例系列分析了美国7家医院17例(14例自体肾、3例移植肾)近期或合并SARS-CoV-2感染患者的肾活检。最常见指征为急性肾损伤(15例)和蛋白尿(11例)。常见病理为急性肾小管损伤(14例)、塌陷性肾小球病(7例)和内皮损伤/血栓性微血管病(6例)。多数患者进展至不可逆肾损伤或需要透析。

要点

  • COVID-19患者即使症状轻微也可出现急性肾损伤和/或大量蛋白尿,需肾活检明确病理。
  • 常见病理包括急性肾小管损伤、塌陷性肾小球病和血栓性微血管病。
  • 多数患者进展至不可逆肾损伤或需要透析,移植受者可能出现抗体介导排斥。

核心结论

  • 即使症状轻微的COVID-19患者也可伴发急性肾损伤和/或大量蛋白尿,肾活检可发现急性肾小管损伤、塌陷性肾小球病和急性内皮损伤等病理改变。
  • 多数患者进展至不可逆肾损伤或需要透析,3例移植受者中2例在COVID-19后数周出现活动性抗体介导排斥。

研究设计与样本

  • 多中心病例系列,纳入美国7家大型医院系统17例(14例自体肾、3例移植肾)因临床指征行肾活检的患者,均有近期或合并SARS-CoV-2感染。

主要发现

  • 17例患者中男女性别均衡,Black患者8例,Hispanic患者5例;所有患者经RT-PCR确诊SARS-CoV-2感染,仅3例表现为重症COVID-19。
  • 活检指征以急性肾损伤(15例)和蛋白尿(11例)最常见,均在COVID-19症状同时或1周内出现。
  • 常见组织学表现:急性肾小管损伤14例,塌陷性肾小球病7例,内皮损伤/血栓性微血管病6例。
  • 3例移植受者中2例在COVID-19后数周出现活动性抗体介导排斥;8例需要透析,其余经保守治疗改善。

临床怎么用

  • 对COVID-19患者出现急性肾损伤或蛋白尿时,应考虑肾活检以明确病理诊断,尤其需警惕塌陷性肾小球病和血栓性微血管病。
  • 移植受者感染SARS-CoV-2后需监测抗体介导排斥,必要时行移植肾活检。

局限性

  • 研究样本量小(17例)且临床随访时间短。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Kidney biopsy data inform us about pathologic processes associated with infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We conducted a multicenter evaluation of kidney biopsy findings in living patients to identify various kidney disease pathology findings in patients with coronavirus disease 2019 (COVID-19) and their association with SARS-CoV-2 infection. STUDY DESIGN: Case series. SETTING & PARTICIPANTS: We identified 14 native and 3 transplant kidney biopsies performed for cause in patients with documented recent or concurrent SARS-CoV-2 infection treated at 7 large hospital systems in the United States. OBSERVATIONS: Men and women were equally represented in this case series, with a higher proportion of Black (n=8) and Hispanic (n=5) patients. All 17 patients had SARS-CoV-2 infection confirmed by reverse transcriptase-polymerase chain reaction, but only 3 presented with severe COVID-19 symptoms. Acute kidney injury (n=15) and proteinuria (n=11) were the most common indications for biopsy and these symptoms developed concurrently or within 1 week of COVID-19 symptoms in all patients. Acute tubular injury (n=14), collapsing glomerulopathy (n=7), and endothelial injury/thrombotic microangiopathy (n=6) were the most common histologic findings. 2 of the 3 transplant recipients developed active antibody-mediated rejection weeks after COVID-19. 8 patients required dialysis, but others improved with conservative management. LIMITATIONS: Small study size and short clinical follow-up. CONCLUSIONS: Cases of even symptomatically mild COVID-19 were accompanied by acute kidney injury and/or heavy proteinuria that prompted a diagnostic kidney biopsy. Although acute tubular injury was seen among most of them, uncommon pathology such as collapsing glomerulopathy and acute endothelial injury were detected, and most of these patients progressed to irreversible kidney injury and dialysis.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Akilesh S, Nast CC, Yamashita M, et al. Multicenter Clinicopathologic Correlation of Kidney Biopsies Performed in COVID-19 Patients Presenting With Acute Kidney Injury or Proteinuria. Am J Kidney Dis. 2020. PMID: 33045255. doi:10.1053/j.ajkd.2020.10.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。